NAS:MNKD (USA) Also Trade In: Germany Israel

MannKind Corp $ 1.56 0.05 (3.31%)

Volume:
4,920,327
Avg Vol (1m):
3,069,065
Market Cap $:
322.00 Mil
Enterprise Value $:
393.46 Mil
P/E (TTM):
0.00
P/B:
0.00
Warning! GuruFocus has detected 2 Severe warning signs with MNKD. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for MNKD (MannKindrp) from 2004 to Feb 23 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. MannKind stock (MNKD) PE ratio as of Feb 23 2020 is 0. More Details

MannKind PE Ratio (TTM) Chart

EMBED

MannKind PE Ratio (TTM) Historical Data

Total 1276
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
MannKind PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2020-02-230.0 2019-12-230.0
2020-02-210.0 2019-12-200.0
2020-02-200.0 2019-12-190.0
2020-02-190.0 2019-12-180.0
2020-02-180.0 2019-12-170.0
2020-02-170.0 2019-12-160.0
2020-02-140.0 2019-12-130.0
2020-02-130.0 2019-12-120.0
2020-02-120.0 2019-12-110.0
2020-02-110.0 2019-12-100.0
2020-02-100.0 2019-12-090.0
2020-02-070.0 2019-12-060.0
2020-02-060.0 2019-12-050.0
2020-02-050.0 2019-12-040.0
2020-02-040.0 2019-12-030.0
2020-02-030.0 2019-12-020.0
2020-01-310.0 2019-11-290.0
2020-01-300.0 2019-11-280.0
2020-01-290.0 2019-11-270.0
2020-01-280.0 2019-11-260.0
2020-01-270.0 2019-11-250.0
2020-01-240.0 2019-11-220.0
2020-01-230.0 2019-11-210.0
2020-01-220.0 2019-11-200.0
2020-01-210.0 2019-11-190.0
2020-01-200.0 2019-11-180.0
2020-01-170.0 2019-11-150.0
2020-01-160.0 2019-11-140.0
2020-01-150.0 2019-11-130.0
2020-01-140.0 2019-11-120.0
2020-01-130.0 2019-11-110.0
2020-01-100.0 2019-11-080.0
2020-01-090.0 2019-11-070.0
2020-01-080.0 2019-11-060.0
2020-01-070.0 2019-11-050.0
2020-01-060.0 2019-11-040.0
2020-01-030.0 2019-11-010.0
2020-01-020.0 2019-10-310.0
2020-01-010.0 2019-10-300.0
2019-12-310.0 2019-10-290.0
2019-12-300.0 2019-10-280.0
2019-12-270.0 2019-10-250.0
2019-12-260.0 2019-10-240.0
2019-12-250.0 2019-10-230.0
2019-12-240.0 2019-10-220.0

MannKind PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Healthcare » Biotechnology » Biotechnology NAICS : 325412 NAICS : 2834
Address 30930 Russell Ranch Road, Suite 300, Westlake Village, CA, USA, 91362
MannKind Corp is a biopharmaceutical company. It is involved in the business of discovery, development, and commercialization of therapeutic products and solutions for the patients with the diseases such as diabetes. Its products and technologies include Afrezza, Dry powder formulation, Inhalation profiling, Oral inhalers and others. The company has following products in the pipeline: Epinephrine technosphere, Treprostinil technosphere, and Palonosetron technosphere.